Citadel Advisors’s Bicara Therapeutics Inc. Common Stock BCAX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$2.06M	Buy	+221,516	New	+$2.06M	﹤0.01%	2662
2024 Q4	–	Sell	-234,122	Closed	-$5.96M	–	6968
2024 Q3	$5.96M	Buy	+234,122	New	+$5.96M	﹤0.01%	1618